Cited by 45Hormonal and reproductive studiesFrailty in Older AdultsNutrition and Health in Aging

Reproductive Hormone Levels Predict Changes in Frailty Status in Community-Dwelling Older Men: European Male Ageing Study Prospective Data

Open access
Swiecicka, Agnieszka, Eendebak, Robert J A H, Lunt, Mark, O’Neill, Terence W, Bartfai, György, Casanueva, Felipe F, Forti, Gianni, Giwercman, Aleksander +10 more·2018·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Clinical sequelae of androgen deficiency share common features with frailty. Evidence supporting the role of androgens in the development of frailty is limited and conflicting. Objective: To determine associations between male reproductive hormones and prospective changes in frailty status. Design/Setting: A 4.3-year prospective cohort study of community-dwelling men participating in the European Male Ageing Study. Participants: A total of 3369 men aged 40 to 79 from eight European centers. Intervention: None. Main Outcome Measure: Frailty status was determined using frailty index (FI; n = 2278) and frailty phenotype (FP; n = 1980). Results: After adjusting for baseline frailty, age, center, and smoking, the risk of worsening FI decreased with higher testosterone (T), free T, and dihydrotestosterone (DHT) [percentage change (95% confidence interval) in FI associated with 1 standard deviation higher hormone level: -3.0 (-5.9, -1.0) for total T; -3.9 (-6.8, -2.0) for free T; and -3.9 (-6.8, -2.0) for DHT]. After further adjustment for body mass index, only free T remained a significant predictor of FI change. In fully adjusted models, higher luteinizing hormone and follicle-stimulating hormone were positively related to worsening FI only in men <60 years, and higher estradiol predicted lower likelihood of improving FP [odds ratio: 0.68 (0.52, 0.88)]. Conclusions: These prospective data support the hypothesis that higher androgen levels may protect elderly men from worsening frailty. However, the causal nature of these relationships requires further investigation. Whereas raised gonadotropins in men <60 years might be an early marker of frailty, the role of estradiol in frailty needs further clarification.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2017-01172

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Low calculated free T, but not total T, is associated with greater likelihood of frailty after adjustment for age, smoking, BMI, and comorbidities.

    “In both cases, after adjusting for age, smoking, BMI and other comorbidities, low levels of calculated free T and not total T concentrations were associated with a greater likelihood of frailty [231].”

    From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [231]

    The Results (Hormonal predictors of worsening frailty; page unavailable) report that only free T remained a significant predictor of worsening frailty index after adjustment for BMI, whereas total T did not. But free T was not significant for worsening frailty phenotype after age adjustment, so the finding does not hold for both frailty measures. The Methods (Statistical analysis; page unavailable) list the study’s adjustments as baseline frailty, age, center, smoking, and BMI—not comorbidities. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. [1]Zaslavsky O, Cochrane BB, Thompson HJ, Woods NF, Herting JR, LaCroix A Frailty: a review of the first decade of research. Biol Res Nurs. 2013; 15(4): 422– 432. 23086382
  2. [2]Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M146– M156. 11253156
  3. [3]Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, Kooperberg CL, Woods NF, LaCroix AZ Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women. Am J Med. 2009; 122(10): 947– 954. 19682668 PMC2754604
  4. [4]Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2014; 167(7) 635– 641. 17420420
  5. [6]Krasnoff JB, Basaria S, Pencina MJ, Jasuja GK, Vasan RS, Ulloor J, Zhang A, Coviello A, Kelly-Hayes M, D’Agostino RB, Wolf PA, Bhasin S, Murabito JM Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab. 2010; 95(6): 2790– 2799. 20382680 PMC2902069
  6. [8]Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Hoffman AR, Lau E, Lane NE, Stefanick ML, Cummings SR, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab. 2009; 94(10): 3806– 3815. 19737923 PMC2758722
  7. [9]Lee DM, O’Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, Wu FC; EMAS study group The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl. 2009; 32(1): 11– 24. 18328041
  8. [10]Ware JE Jr, Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6): 473– 483. 1593914
  9. [11]Washburn RA, Smith KW, Jette AM, Janney CA The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993; 46(2): 153– 162. 8437031
  10. [12]National Child Traumatic Stress Network—Child Trauma Home. Beck Depression Inventory Second Edition (BDI-II). Available at: www.nctsn.org/content/beck-depression-inventory-second-edition-bdi-ii. Accessed 11 October 2015.
  11. [13]Bosch JL, Hop WC, Kirkels WJ, Schröder FH The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995; 75(5): 622– 630. 7542132
  12. [14]Reuben DB, Siu AL An objective measure of physical function of elderly outpatients. The Physical Performance Test. J Am Geriatr Soc. 1990; 38(10): 1105– 1112. 2229864
  13. [15]Tinetti ME, Williams TF, Mayewski R Fall risk index for elderly patients based on number of chronic disabilities. Am J Med. 1986; 80(3): 429– 434. 3953620
  14. [16]Osterrieth PA, Osterrieth PA Le test de copie d’une figure complexe: contribution a l’étude de la perception et de la memoire. Arch Psychol. 1944; 1944(30): 286– 356.
  15. [17]Warrington E The Camden Memory Tests: Topographical Recognition Memory Test. East Sussex, UK: Psychology Press; 1996.
  16. [19]Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K A standard procedure for creating a frailty index. BMC Geriatr. 2008; 8(1): 24. 18826625 PMC2573877
  17. [20]O’Connell MDLO, Tajar A, O’Neill TW, Roberts SA, Lee DM, Pye SR, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC Frailty is associated with impaired quality of life and falls in middle-aged and older European men. J Frailty Aging. 2013; 2(2): 77– 83. 27070662
  18. [21]Vermeulen A, Verdonck L, Kaufman JM A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84(10): 3666– 3672. 10523012
  19. [23]Travison TG, Nguyen A-H, Naganathan V, Stanaway FF, Blyth FM, Cumming RG, Le Couteur DG, Sambrook PN, Handelsman DJ Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metab. 2011; 96(8): 2464– 2474. 21677041
  20. [25]Auyeung TW, Lee JSW, Kwok T, Leung J, Ohlsson C, Vandenput L, Leung PC, Woo J Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol. 2011; 164(5): 811– 817. 21346095
  21. [27]Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2007; 167(7): 635– 641. 17420420
  22. [28]Finkelstein JS, Lee H, Burnett-Bowie S-AM, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013; 369(11): 1011– 1022. 24024838 PMC4142768
  23. [29]Schaap LA, Pluijm SMF, Smit JH, van Schoor NM, Visser M, Gooren LJ, Lips P The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol (Oxf). 2005; 63(2): 152– 160. 16060908
  24. [30]Gielen E, O’Neill TW, Pye SR, Adams JE, Wu FC, Laurent MR, Claessens F, Ward KA, Boonen S, Bouillon R, Vanderschueren D, Verschueren S Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle. 2015; 6(3): 242– 252. 26401471 PMC4575556
  25. [31]Arnal JF, Scarabin PY, Trémollières F, Laurell H, Gourdy P Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol. 2007; 18(5): 554– 560. 17885427

Cited by

Sorted by citations

Authors
Swiecicka, A., Eendebak, R. J. A. H., Lunt, M., O’Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., Giwercman, A., Han, T. S., Slowikowska-Hilczer, J., Lean, M. E. J., Pendleton, N., Punab, M., Vanderschueren, D., Huhtaniemi, I. T., Wu, F. C. W., Rutter, M. K., & European Male Ageing Study Group
Affiliations
  • Andrology Research Unit, Division of Diabetes, Endocrinology, and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
  • Manchester Academic Health Science Centre (GB)
  • Department of Obstetrics, Gynaecology, and Andrology, Albert Szent-Györgyi Medical University, Szeged, Hungary
  • Complejo Hospitalario Universitario de Santiago (ES)
  • University of Florence (IT)
  • Lund University (SE)
  • Royal Holloway University of London (GB)
  • Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, Lodz, Poland
  • University of Glasgow (GB)
  • University of Manchester (GB)
  • Tartu University Hospital (EE)
  • KU Leuven (BE)
  • University of Turku (FI)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-11-24
Volume
103
Issue
2
Pages
701-709
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2766529636
Cited by
45
References
5
Citations by year
2026: 2 · 2025: 10 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 10 · 2018: 2
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Lirias (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
National Institute for Health Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
frailty, male reproductive hormones, androgen deficiency, testosterone, free testosterone, dihydrotestosterone, luteinizing hormone, follicle-stimulating hormone, estradiol, frailty index, Fried frailty phenotype, community-dwelling older men, European Male Ageing Study
MeSH terms
Frailty, Adult, Aged, Aging, Europe, Humans, Male, Middle Aged, Prognosis, Cohort Studies, Geriatric Assessment, Frail Elderly, Gonadal Hormones, Independent Living

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review